British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating Covid patients at risk of severe complications. AstraZeneca, whose separate Covid vaccine rollout has been hampered by health concerns, said its trial assessing t ..
P=0.046)
The TAVR group had had more deaths and strokes between 1 and 2 years compared with the SAVR group, according to the PARTNER 3 investigators led by Martin Leon, MD, of Columbia University Irving Medical Center in New York City. Their report was published in the March 9 issue of the Clearly, ongoing assessment of clinical and echocardiographic findings is needed in younger and low-risk patients and planned follow-up in PARTNER 3 will continue through at least 10 years, Leon and colleagues wrote.
The convergence in death and stroke came as no surprise to cardiac surgeon Joseph Bavaria, MD, of the Hospital of the University of Pennsylvania in Philadelphia, who participated in the trial.
After COVID-19, athletes at lower risk for developing myocarditis than originally thought kshb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kshb.com Daily Mail and Mail on Sunday newspapers.
Concern raised over iPhone 12 potentially disabling implanted heart devices
Doctors are concerned the magnets in the iPhone 12 could disable implanted medical devices.
and last updated 2021-02-17 08:23:51-05
KANSAS CITY, Mo. â Medical research has shown the new iPhone 12 could disable implanted heart devices, like the pacemaker or defibrillator.
Findings from the Heart Rhythm Society reported internal magnets are so strong that the phone could interfere with the heart devices.
The nonprofit focuses on cardiac rhythm disorders.
In its report, it says, We hereby report an important public health issue concerning the newer-generation iPhone 12, which potentially can inhibit lifesaving therapy in a patient, particularly when the phone is carried in an upper chest pocket.
Michael Precker American Heart Association News
Keeping track of your heart rate is probably a good thing. Obsessing about it probably isn’t.
That’s one drawback of the increasing popularity of wearable devices that constantly monitor heart rates, said Dr. Tracy Stevens, a cardiologist at Saint Luke’s Mid America Heart Institute in Kansas City, Missouri.
“I’ve had people suffer significant injuries when they’re trying to check their heart rate while exercising,” she said. “They take a hand off their treadmill and shoot right off the back and fall off.”
Even without a monitor, the preoccupation can have consequences.